scispace - formally typeset
S

Susan M. Thorpe

Researcher at Novo Nordisk

Publications -  47
Citations -  2023

Susan M. Thorpe is an academic researcher from Novo Nordisk. The author has contributed to research in topics: Breast cancer & Estrogen receptor. The author has an hindex of 25, co-authored 47 publications receiving 1995 citations.

Papers
More filters
Journal Article

Association between High Concentrations of Mr 52,000 Cathepsin D and Poor Prognosis in Primary Human Breast Cancer

TL;DR: It is demonstrated that the level of Mr 52,000 cathepsin D in cytosol of primary breast cancer biopsies is an independent prognostic factor in predicting relapses in both pre/peri- and postmenopausal patients.
Journal Article

Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.

TL;DR: Qualitative assessment of receptor status was as valuable as quantitative expression of receptor concentrations in predicting the RFS of the natural course of the disease among node negative premenopausal patients.
Journal Article

Prognostic Usefulness of Estrogen Receptor Immunocytochemical Assays for Human Breast Cancer

TL;DR: It was found that a combination of the distribution of ER-ICA stained cells and the overall staining intensity gave a statistically significant correlation with the quantitative estrogen receptor dextran-coated charcoal steroid binding assay value.
Journal ArticleDOI

Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance

TL;DR: This paper outlines the changes which have occurred over the last 25 years in the methods employed for the measurement of oestrogen receptors to aid the management of women with breast cancer and discusses the advantages and pitfalls of the immunohistochemical assay.